pharmaphorum

JANUARY 15, 2021

Emulating on the first edition in 2020, the 2 nd Manufacturing Assets & Facility Management i n Pharma (MAFM) Summit will return in May, dedicated to aiding Engineering, Maintenance & Manufacturing Facilities leaders to collaborate. to utilize predictive maintenance programs.

Manufacturing 52

Manufacturing Engineer Production 52

Pharmaceutical Technology

OCTOBER 13, 2022

In hope of getting to the heart of these problems – and uncovering possible solutions – Alfa, an asset financing software provider and Capitas Finance, a low-carbon finance specialist, have released a new whitepaper on the topic. They need to manage it now.” This is where new approaches to financing efficient energy assets can help.

Regulation 130

Regulation Marketing Manufacturing Sales 130

XTalks

AUGUST 11, 2023

Healthcare facilities management is a comprehensive approach to overseeing the various facets of healthcare facilities, spanning their development, maintenance, security and operations. This is achieved by synergizing facilities, assets and personnel to uphold the highest patient care standards.

Compliance 96

Compliance Contamination Production Marketing 96

Cloudbyz

NOVEMBER 3, 2021

Biosamples and biomarkers are the core basis for much of the work done in the clinical research industry and proficient Human Biosample Management (HBSM) is necessary to procure reliable biosamples. Knowing that integrating software into your Human Biosample Management structure is trending is a given. Software Integration.

Biobanking 52

Biobanking Clinical Research Contamination Research 52

XTalks

JANUARY 17, 2024

RWD is a critical asset in lupus research, offering a thorough view of the disease’s complexities. In essence, RWD empowers researchers, healthcare providers and patients to better understand and manage lupus, leading to improved care and outcomes. Lupus varies widely among patients, and understanding this diversity is challenging.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

The Pharma Data

NOVEMBER 5, 2020

billion bridge loan facility, which was previously entered into in May 2020 in connection with the Company’s purchase of shares of its common stock held by Sanofi. Net proceeds to the Company from the issuance and sale of the notes were used in part to repay the $1.5

Sales 52

Sales Production Manufacturing Antibody 52

The Pharma Data

MAY 4, 2021

Additionally, Pfizer published this morning on its website the first-quarter 2021 earnings presentation and accompanying prepared remarks from management. Panzyga is the only intravenous immunoglobulin (IVIg) with two FDA-approved maintenance dosing options for CIDP. EXECUTIVE COMMENTARY. A decision from the EC is expected in 2022.

Vaccination 40

Vaccination Vaccine Production Sales 40